Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type

Saved in:
Bibliographic Details
Main Authors: Satish Maharaj, Simone Chang
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.1059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850115615708151808
author Satish Maharaj
Simone Chang
author_facet Satish Maharaj
Simone Chang
author_sort Satish Maharaj
collection DOAJ
format Article
id doaj-art-e9943b7229ca40c281cf746fc0aafabb
institution OA Journals
issn 2688-6146
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series eJHaem
spelling doaj-art-e9943b7229ca40c281cf746fc0aafabb2025-08-20T02:36:31ZengWileyeJHaem2688-61462024-12-01561363136510.1002/jha2.1059Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal typeSatish Maharaj0Simone Chang1Department of Hematology/Oncology University of South Florida Tampa Florida USADepartment of Hematology/Oncology University of South Florida Tampa Florida USAhttps://doi.org/10.1002/jha2.1059immunotherapylymphomaNK/T-cellreaction
spellingShingle Satish Maharaj
Simone Chang
Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
eJHaem
immunotherapy
lymphoma
NK/T-cell
reaction
title Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
title_full Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
title_fullStr Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
title_full_unstemmed Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
title_short Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
title_sort low dose nivolumab for extranodal natural killer t cell lymphoma nasal type
topic immunotherapy
lymphoma
NK/T-cell
reaction
url https://doi.org/10.1002/jha2.1059
work_keys_str_mv AT satishmaharaj lowdosenivolumabforextranodalnaturalkillertcelllymphomanasaltype
AT simonechang lowdosenivolumabforextranodalnaturalkillertcelllymphomanasaltype